Tekenbeten en de ziekte van Lyme
Leïla Belkhir, Dirk Vogelaers(AZ Delta), Sophie Quoilin, Veroniek Saegeman, Koen Magerman, Steven Van Den Broucke(Instituut voor Tropische Geneeskunde), Benoît Kabamba Mukadi, Hector Rodriguez‐Villalobos(Cliniques Universitaires Saint-Luc), Frédéric Frippiat(University of Liège), Geert De Loof, Paul De Munter(KU Leuven), Camélia Rossi(CHU Ambroise Paré), Patrick Lacor, Dimitri Van der Linden, Bénédicte Delaere, Tinne Lernout(Sciensano (Belgium)), Frédérique Jacobs(Université Libre de Bruxelles), Yves Van Laethem(Centre Hospitalier Universitaire de Saint-Pierre)
Cited by 1
Related Papers
Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study
|European Archives of Oto-Rhino-Laryngology|2020|2.8k
Clinical and epidemiological characteristics of 1420 European patients with mild‐to‐moderate coronavirus disease 2019
|Journal of Internal Medicine|2020|847
Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial
|The Lancet|2007|689
Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium
|Clinical Microbiology and Infection|2007|575
Clinical and Economic Outcomes in Critically Ill Patients with Nosocomial Catheter-Related Bloodstream Infections
|Clinical Infectious Diseases|2005|425